Shubham Misra: CCL2 As a Potential Biomaker for Post-Stroke Seizures, Epileptiform Discharges and Mortality
Shubham Misra, Postdoctoral Associate at Yale Department of Neurology, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Our latest study, published in PLOS One, identifies the role of CCL2 as a potential biomarker associated with late seizures and epileptiform discharges (SED) and 90-day mortality post SED in ICH patients.”
Title: Characterizing inflammatory biomarkers in post-stroke seizure risk and outcome prognostication
Authors: Ethan Y. Wang, Shubham Misra, Jennifer Yan, Pei Yi Chook, Yuki Kawamura, Rachel Kitagawa, Jennifer A. Kim, Emily J. Gilmore, Adam de Havenon, Adithya Sivaraju, Lawrence J. Hirsch, Guido J. Falcone, Srikant Rangaraju, Lauren H. Sansing, Jessica Magid-Bernstein, Nishant K. Mishra
Read the Full Article on PLOS One
Stay updated on all scientific advances with Hemostasis Today.
-
Jun 1, 2026, 18:51Francesco Giurazza: New Publication on Glubran-2 in Acute Bleeding Patients with Coagulopathies
-
Jun 1, 2026, 18:50Donald Arnold is the Recipient of the Roberts Award – ISTH
-
Jun 1, 2026, 18:49Amirreza Jabbaripour Sarmadian: My First Paper as Corresponding Author on Upper Extremity DVT Following COVID-19 Vaccination
-
Jun 1, 2026, 18:49James P. Crowley: How Combining Vitamin D analogs with Chemotherapy Impacts Survival Outcomes
-
Jun 1, 2026, 18:42Debojyoti Chakraborty: Small But Meaningful Steps Toward A Gene Editing Trial For Sickle Cell Disease In India
-
Jun 1, 2026, 17:14Tiffany Gacel: What an Incredible Day With NBCA and The Red Bus Tour at Memorial at Gulfport?
-
Jun 1, 2026, 17:12Marie-Claire Kofi: Poster Highlights the Process of Establishing the Sickle Cell Transitions Policy Lab
-
Jun 1, 2026, 17:00Azusa Nagao: Organizing the Symposium on Women and Bleeding Disorders at JSTH Annual Meeting
-
Jun 1, 2026, 16:57Kuljeet Kaur: Approach to Anemia – More Than Just a Low Hemoglobin